Back

Ranolazine reduces levosimendan-mediated atrial fibrillation in an experimental whole-heart model

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Arrhythmia mechanisms - General Antiarrhythmic Drug Treatment ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Gerrit Frommeyer

University Hospital of Munster, Munster (Germany)

10 More presentations in this session

Presentation thumbnail
Sudden cardiac arrest in patients without overt heart disease - Clinical assessment, family screening and genetic testing by next generation sequencing.
Doctor M. Stepien-Wojno (Warsaw, PL)
Abstract
Presentation thumbnail
Validation of the indication for implantable cardioverter defibrillator in Brugada syndrome in the J Wave Syndromes Consensus Conference
Professor M. Takagi (Moriguchi, JP)
Abstract
Presentation thumbnail
GENECHOC study: a study designed to identify the genetic variants involved in appropriate shock in primary prevention; clinical description of the patients
Professor V. Probst (Nantes, FR)
Abstract
Presentation thumbnail
Drug-testing using human-induced pluripotent stem cell-derived cardiomyocytes from a patient with short QT syndrome
Mrs Z. Zhao (Mannheim, DE)
Abstract
Presentation thumbnail
Late gadolinium enhancement at cardiac magnetic resonance accurately predicts arrhythmias in patients with non-ischemic cardiomyopathy
Doctor C. Raineri (Turin, IT)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Arrhythmia mechanisms - General

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources